Trials / Unknown
UnknownNCT02702973
Characteristic Analysis of Retinopathy Associated With High Doses of Interferon α-2b Therapy
Characteristic Analysis of Retinopathy Associated With High Doses of Interferon α-2b Therapy in Patients With Melanomas of the Skin
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 1 (estimated)
- Sponsor
- The First Hospital of Jilin University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The high doses of interferon α-2b therapy in patients with melanomas of the skin may induced retinopathy, especially in the patients with hypertension or diabetes, so these patients should be followed up after treatment.
Detailed description
Patients with melanomas of the skin whose tumors have been resected completely were collected. The detailed ocular examinations including intraocular pressure, slit lamp microscope, indirect ophthalmoscope and color fundus photography were done before the induction therapy, 2 weeks after the induction therapy, after the whole course of induction therapy and each month in the maintenance treatment period. Fundus examinations were carried out by experienced ocular fundus doctors and the retinopathy characteristics were recorded.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Observe the fundus characteristics after therapy. |
Timeline
- Start date
- 2015-12-01
- Primary completion
- 2017-10-01
- Completion
- 2017-10-01
- First posted
- 2016-03-09
- Last updated
- 2016-03-09
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02702973. Inclusion in this directory is not an endorsement.